Cite
APA Citation
Lightner, A. L., Dadgar, N., Matyas, C., Elliott, K., Fulmer, C., Khaitan, N., Ream, J., Nachand, D., & Steele, S. R. (2022). a phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis. Colorectal disease, 24, 1358–1370. http://access.bl.uk/ark:/81055/vdc_100170365529.0x000020